Skip to main content
Erschienen in: European Surgery 2/2014

01.04.2014 | Short Communication

Selected commentary to review on novel concepts of columnar lined esophagus

verfasst von: L. Bonavina, MD

Erschienen in: European Surgery | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Summary

The focus of this review article is on the novel and challenging concepts that have emerged in the field of gastroesophageal reflux disease (GERD) and Barrett’s esophagus over the recent years. Lenglinger et al. (Wien Klin Wochenschr. 2013;125:577–590) have made an in-depth PubMed research on studies dealing with histopathology of nondysplastic columnar lined esophagus (CLE). The aim of the review is to summarize the current body of knowledge regarding the pathophysiology of nondysplastic CLE and its implications for the diagnosis and treatment of this pre-neoplastic condition.
Literatur
1.
Zurück zum Zitat Lenglinger J, Fischer See S, Beller L, et al. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013;125:577–90.CrossRef Lenglinger J, Fischer See S, Beller L, et al. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013;125:577–90.CrossRef
2.
Zurück zum Zitat Chandrasoma P, Wijetunge S, Ma Y, et al. The dilated distal esophagus: a new entity that is the pathologic basis of early gastroesophageal reflux disease. Am J Surg Pathol. 2011;35:1873–81.PubMedCrossRef Chandrasoma P, Wijetunge S, Ma Y, et al. The dilated distal esophagus: a new entity that is the pathologic basis of early gastroesophageal reflux disease. Am J Surg Pathol. 2011;35:1873–81.PubMedCrossRef
3.
Zurück zum Zitat Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522–32.PubMedCentralPubMedCrossRef Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522–32.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Barrett NR. Chronic peptic ulcer of the oesophagus and “oesophagitis”. Br J Surg. 1950;38:175–82.PubMedCrossRef Barrett NR. Chronic peptic ulcer of the oesophagus and “oesophagitis”. Br J Surg. 1950;38:175–82.PubMedCrossRef
6.
Zurück zum Zitat Chandrasoma PT, DeMeester TR. GERD. Reflux to esophageal adenocarcinoma. Elsevier Academic Press, 2006. Chandrasoma PT, DeMeester TR. GERD. Reflux to esophageal adenocarcinoma. Elsevier Academic Press, 2006.
7.
Zurück zum Zitat Fischer See S, Schoppmann SF, Riegler M, Zacherl J. Radiofrequency ablation and antireflux management for non-dysplastic Barrett’s esophagus. In: Bonavina L, editor. Innovation in esophageal surgery. Italia: Springer-Verlag; 2012. pp. 27–41. Fischer See S, Schoppmann SF, Riegler M, Zacherl J. Radiofrequency ablation and antireflux management for non-dysplastic Barrett’s esophagus. In: Bonavina L, editor. Innovation in esophageal surgery. Italia: Springer-Verlag; 2012. pp. 27–41.
8.
Zurück zum Zitat Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–88. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.
9.
Zurück zum Zitat Gurski R, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive factors. J Am Coll Surg. 2003;196:706–12.PubMedCrossRef Gurski R, Peters JH, Hagen JA, et al. Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive factors. J Am Coll Surg. 2003;196:706–12.PubMedCrossRef
10.
Zurück zum Zitat Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.PubMedCentralPubMed Parrilla P, Martinez de Haro LF, Ortiz A, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237:291–8.PubMedCentralPubMed
11.
Zurück zum Zitat Martinez de Haro LF, Ortiz A, Parrilla P, et al. Long-term follow-up of malignancy biomarkers in patients with Barrett’s esophagus undergoing medical or surgical treatment. AnnSurg. 2012;255:916–21. Martinez de Haro LF, Ortiz A, Parrilla P, et al. Long-term follow-up of malignancy biomarkers in patients with Barrett’s esophagus undergoing medical or surgical treatment. AnnSurg. 2012;255:916–21.
12.
Zurück zum Zitat Souza R, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776–84.PubMedCrossRef Souza R, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776–84.PubMedCrossRef
13.
Zurück zum Zitat Huo X, Zhang HY, Zhang X, et al. Acid and bile salt induced CDX 2 expression differs in squamous cells from patients with and without Barrett’s esophagus. Gastroenterology. 2010;139:194–203.PubMedCentralPubMedCrossRef Huo X, Zhang HY, Zhang X, et al. Acid and bile salt induced CDX 2 expression differs in squamous cells from patients with and without Barrett’s esophagus. Gastroenterology. 2010;139:194–203.PubMedCentralPubMedCrossRef
14.
Metadaten
Titel
Selected commentary to review on novel concepts of columnar lined esophagus
verfasst von
L. Bonavina, MD
Publikationsdatum
01.04.2014
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 2/2014
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-014-0260-1

Weitere Artikel der Ausgabe 2/2014

European Surgery 2/2014 Zur Ausgabe